In these 14 Member States, therefore, it is unclear for patients exactly which treatments are subject to prior authorisation, since the use of at least one of these criteria - and sometimes both - has not been elucidated by national authorities.
U tih je 14 država članica, dakle, pacijentima nejasno koja liječenja podliježu prethodnom odobrenju jer nadležna tijela nisu razjasnila kad se primjenjuje najmanje jedan od tih kriterija, a ponekad i oba.